Pubblicazioni

TRPA1 Contributes to FGFR2c Signaling and to Its Oncogenic Outcomes in Pancreatic Ductal Adenocarcinoma-Derived Cell Lines

2024 - CANCERS

Mancini, Vanessa; Raffa, Salvatore; Fiorio Pla, Alessandra; French, Deborah; Torrisi, Maria Rosaria; Ranieri, Danilo; Belleudi, Francesca

Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC

2024 - CANCERS

Farina, A.; Viggiani, V.; Cortese, F.; Moretti, M.; Tartaglione, S.; Angeloni, A.; Anastasi, E.

Combination Therapy with a Bispecific Antibody Targeting the hERG1/Î²1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma

2023 - CANCERS

Lottini, Tiziano; Duranti, Claudia; Iorio, Jessica; Martinelli, Michele; Colasurdo, Rossella; NicolÃ¡s DâAlessandro, Franco; Buonamici, Matteo; Coppola, Stefano; Devescovi, Valentina; La Vaccara, Vincenzo; Coppola, Alessandro; Coppola, Roberto; Lastraioli, Elena; Arcangeli, Annarosa

Role of fgfr2c and its pkcÎµ downstream signaling in the control of emt and autophagy in pancreatic ductal adenocarcinoma cells

2021 - CANCERS

Ranieri, D.; Guttieri, L.; Raffa, S.; Torrisi, M. R.; Belleudi, F.